Witryna11 kwi 2024 · Impel Pharmaceuticals is a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs. Impel offers treatments that pair its proprietary POD ® technology with well-established therapeutics. Witryna15 lis 2024 · Impel, POD and the Impel logo are trademarks of Impel NeuroPharma, Inc. To learn more about Impel NeuroPharma, please visit our website at …
Impel Pharmaceuticals Announces Strategic Reprioritization, …
Witryna24 mar 2024 · Impel Pharmaceuticals Inc. (IMPL) came out with a quarterly loss of $0.97 per share versus the Zacks Consensus Estimate of a loss of $1.04. This compares to loss of $1.07 per share a year ago.... entergy bill pay ms
Impel Pharmaceuticals Announces Fourth Quarter and Full Year …
WitrynaImpel Pharmaceuticals Inc. is a Seattle-based, commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high … Witryna11 kwi 2024 · SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, announced today that four Trudhesa ® (dihydroergotamine mesylate) … WitrynaImpel Pharmaceuticals Inc. is a Seattle-based, commercial-stage pharmaceutical company developing first-in-class intranasal drug treatments for disorders with high … entergy bill credit mississippi